1.Single-pill combinations for hypertension: first line treatment for all?

Shao, L, Chan, P, To     More...

Shao, L, Chan, P, Tomlinson, B, Zhang, YZ, Liu, ZM     Less

CURRENT MEDICAL RESEARCH AND OPINION[0300-7995], Published 2019, Volume 35, Issue 1, Pages 113-115

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2022影響因子:  2.3  发表年影響因子:  2.271 

2.Attaining cholesterol goals: will aiming for lower targets improve the score?

Leong, IL, Tomlinson     More...

Leong, IL, Tomlinson, B, Zhang, YZ, Chan, P, Liu, ZM     Less

CURRENT MEDICAL RESEARCH AND OPINION[0300-7995], Published 2018, Volume 34, Issue 2, Pages 297-299

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2022影響因子:  2.3  发表年影響因子:  2.345 

3.Liraglutide for weight management: benefits and risks

Tomlinson, B, Hu, M,     More...

Tomlinson, B, Hu, M, Zhang, YZ, Chan, P, Liu, ZM     Less

CURRENT MEDICAL RESEARCH AND OPINION[0300-7995], Published 2017, Volume 33, Issue 3, Pages 537-539

收錄情况： WOS SCOPUS

WOS核心合集引用: 1  2022影響因子:  2.3  发表年影響因子:  2.665 

4.Practical considerations for the use of sodium-glucose co-transporter type 2 inhibitors in treating hyperglycemia in type 2 diabetes

Lam, KSL, Chow, CC,     More...

Lam, KSL, Chow, CC, Tan, KCB, Ma, RCW, Kong, APS, Tong, PCY, Tsang, MW, Chan, TM, Tang, SCW, Lee, KK, So, WY, Tomlinson, B     Less

CURRENT MEDICAL RESEARCH AND OPINION[0300-7995], Published 2016, Volume 32, Issue 6, Pages 1097-1108

收錄情况： WOS SCOPUS

WOS核心合集引用: 11  2022影響因子:  2.3  发表年影響因子:  2.757 

5.The use of medications in the secondary prevention of coronary artery disease in the Asian region

Dalal, J, Low, LP, P     More...

Dalal, J, Low, LP, Phuoc, DV, Rahman, ARA, Reyes, E, Soenarta, AA, Tomlinson, B     Less

CURRENT MEDICAL RESEARCH AND OPINION[0300-7995], Published 2015, Volume 31, Issue 3, Pages 423-433

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2022影響因子:  2.3  发表年影響因子:  2.643 

6.Combination therapy in hypertension: an Asia-Pacific consensus viewpoint

Rahman, ARA, Reyes,     More...

Rahman, ARA, Reyes, EB, Sritara, P, Pancholia, A, Van Phuoc, D, Tomlinson, B     Less

CURRENT MEDICAL RESEARCH AND OPINION[0300-7995], Published 2015, Volume 31, Issue 5, Pages 865-874

收錄情况： WOS SCOPUS

WOS核心合集引用: 7  2022影響因子:  2.3  发表年影響因子:  2.643 

7.The role of beta-blockers in the management of hypertension: An Asian perspective

Tomlinson, B, Dalal,     More...

Tomlinson, B, Dalal, JJ, Huang, J, Low, LP, Park, CG, Rahman, AR, Reyes, EB, Soenarta, AA, Heagerty, A, Follath, F     Less

CURRENT MEDICAL RESEARCH AND OPINION[0300-7995], Published 2011, Volume 27, Issue 5, Pages 1021-1033

收錄情况： WOS SCOPUS

WOS核心合集引用: 12  2022影響因子:  2.3  发表年影響因子:  2.380 

8.A randomised study comparing the efficacy and safety of rosuvastatin with atorvastatin for achieving lipid goals in clinical practice in Asian patients at high risk of cardiovascular disease (DISCOVERY-Asia study)

Zhu, JR, Tomlinson,     More...

Zhu, JR, Tomlinson, B, Ro, YM, Sim, KH, Lee, YT, Sriratanasathavorn, C     Less

CURRENT MEDICAL RESEARCH AND OPINION[0300-7995], Published 2007, Volume 23, Issue 12, Pages 3055-3068

收錄情况： WOS SCOPUS

WOS核心合集引用: 37  2022影響因子:  2.3  发表年影響因子:  2.962